HLA-G and myalgic encephalomeyelitis/chronic fatigue syndrome: In that study, it was suggested that miR-152 may be involved in the reduced cytotoxic activity often reported in patients with ME/CFS, via targeting inhibitory human leukocyte antigen G (HLA-G).